Koers Sirona Biochem Corp Toronto S.E.
Aandelen
SBM
CA82967M1005
Biotechnologie & Medisch Onderzoek
Omzet 2022 | 672K 490K 456K | Omzet 2023 | 34,78K 25,35K 23,61K | Marktkapitalisatie | 21,44 mln. 15,62 mln. 14,55 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -3 mln. -2,19 mln. -2,04 mln. | Nettowinst (verlies) 2023 | -2 mln. -1,46 mln. -1,36 mln. | EV/omzet 2022 | 48,8 x |
Nettoschuld 2022 | 48,04K 35,01K 32,61K | Nettoschuld 2023 | 1,61 mln. 1,17 mln. 1,09 mln. | EV/omzet 2023 | 663 x |
K/w-verhouding 2022 |
-8,81
x | K/w-verhouding 2023 |
-8,43
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 89,41% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Howard Verrico
CEO | Chief Executive Officer | - | 19-10-06 |
Director of Finance/CFO | - | 29-04-09 | |
Chief Tech/Sci/R&D Officer | - | 31-03-11 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Howard Verrico
CEO | Chief Executive Officer | - | 19-10-06 |
Alex Marazzi
BRD | Director/Board Member | - | 19-10-06 |
Director of Finance/CFO | - | 29-04-09 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+38,66% | 53,67 mld. | |
+33,67% | 38,86 mld. | |
-7,81% | 38,76 mld. | |
-10,77% | 27,27 mld. | |
+11,77% | 25,91 mld. | |
-17,82% | 20,29 mld. | |
+35,09% | 12,78 mld. | |
+29,17% | 12,18 mld. | |
-3,05% | 11,96 mld. |